is part of the Informa Markets Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
The pharmaceutical product lifecycle is a complex process with several touchpoints that needs to balance efficient deployment of essential medicines to patients with strict safety compliance, in one of the world’s most heavily regulated sectors.
The global emergency that is COVID-19 has exerted even more pressure on pharmaceutical supply chains, as the industry races not only to develop potential vaccines and therapies for the virus in record time but also to scale up manufacturing to make these treatments available to a global population.
Each year we unite more than 100,000 pharmaceutical professionals through exhibitions, conferences and online communities. Global Pharma Insights provides information to aid effective decision making in all the following sectors and more:
• Drug development (pre-clinical and clinical) • API sourcing and procurement • Drug manufacturing and outsourcing • Pharmaceutical packaging and drug delivery • Pharmaceutical distribution • Cell and gene therapies • Cell and gene therapies • Artificial intelligence and machine learning
The ongoing pandemic has fuelled debate about whether Western pharmaceutical supply chains and API sourcing are too dependent on lower-cost Asian suppliers such as China. Do the US and Europe need to bring manufacturing back home?
CPhI Worldwide is closely monitoring developments concerning the Coronavirus COVID-19. The health and safety of both our customers and colleagues is always our top priority. As such, we are following all safety advice and precautions as recommended by local Departments of Health, as well as the World Health Organization (WHO).
Players in the pharmaceutical value chain will need to fully harness cutting-edge digital technologies such as artificial intelligence (AI) and cyber-security solutions to make greater efficiency...
South Africa and Kenya represent the best opportunities for pharmaceutical manufacturing firms thinking of investing in Sub-Saharan Africa, according to Martin Tronquit, Managing Partner at data...
The CPhI Annual Report is a comprehensive and critically important publication that analyses key trends and innovations forecast by our panel of world class experts.
Running as a series of opinions and articles, the CPhI experts call upon their considerable commercial and technical acumen to prophesize the future direction, technologies, opportunities and threats in pharma. It’s an essential read for executives who wish to get a head start today on the shape of tomorrow’s industry.
We are at a crucial point in pharma manufacturing as newer technologies and changing pipelines, in addition to demand for lower cost drugs, join forces to change how drugs will be manufactured in the future. This marks the beginning of an age of smart pharma manufacturing, as the industry takes centre stage in advancing medicine.
Find out how changing pipelines of smaller volume drugs, coupled with new technologies, not only transform industry attrition rates, but also change the machinery used in pharma manufacturing.